Atai Life Sciences Retained Earnings (Accumulated Deficit) 2020-2024 | ATAI
Atai Life Sciences retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Atai Life Sciences Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-551 |
| 2022 | $-510 |
| 2021 | $-358 |
| 2020 | $-190 |
| 2019 | $-20 |
| Atai Life Sciences Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-661 |
| 2024-06-30 | $-635 |
| 2024-03-31 | $-578 |
| 2023-12-31 | $-551 |
| 2023-09-30 | $-533 |
| 2023-06-30 | $-577 |
| 2023-03-31 | $-544 |
| 2022-12-31 | $-510 |
| 2022-09-30 | $-465 |
| 2022-06-30 | $-431 |
| 2022-03-31 | $-395 |
| 2021-12-31 | $-358 |
| 2021-09-30 | $-269 |
| 2021-06-30 | $-238 |
| 2021-03-31 | $-189 |
| 2020-12-31 | $-190 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $-20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.252B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.703B | 0.00 |
| Quest Diagnostics (DGX) | United States | $17.349B | 17.58 |
| DaVita (DVA) | United States | $14.249B | 18.43 |
| Encompass Health (EHC) | United States | $9.629B | 22.70 |
| Chemed (CHE) | United States | $8.394B | 25.80 |
| Elanco Animal Health (ELAN) | United States | $6.076B | 14.46 |
| Option Care Health (OPCH) | United States | $5.267B | 24.96 |
| RadNet (RDNT) | United States | $4.972B | 110.11 |
| LifeStance Health (LFST) | United States | $3.092B | 0.00 |
| Amedisys (AMED) | United States | $3.023B | 21.51 |
| Addus HomeCare (ADUS) | United States | $2.290B | 26.87 |
| Astrana Health (ASTH) | United States | $2.076B | 28.39 |
| U.S Physical Therapy (USPH) | United States | $1.337B | 35.14 |
| Pennant (PNTG) | United States | $0.945B | 38.21 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.945B | 0.00 |
| Bioqual (BIOQ) | United States | $0.055B | 0.00 |
| Daxor (DXR) | United States | $0.038B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.004B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |